{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:44:49Z","timestamp":1762508689298,"version":"3.40.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760799"],"award-info":[{"award-number":["81760799"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The purpose of this study is to determine the efficacy and safety of Cyclosporine A (CsA) for patients with steroid-resistant nephrotic syndrome (SRNS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This study will be designed following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols statement guidelines. Studies are identified through systematic searches in November 2021 with no restrictions on date and time, and publication status using the following bibliographic databases: Embase, Medline, PubMed, Web of Science, Science Direct, and the Cochrane Library. The risk of bias of included studies is estimated by taking into consideration the characteristics including random sequence generation, allocation concealment, blinding of patients, blinding of outcome assessment, completeness of outcome data, selective reporting, and other bias by Cochrane Collaboration's tool. Data synthesis and analyses are performed using Stata version 10.0 software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The results of this systematic review and meta-analysis will be published in a peer-reviewed journal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>CsA may be an effective and safe therapy for SRNS. However, additional randomized controlled studies are needed to thoroughly assess the role of CsA in the treatment of SRNS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Open Science Framework registration number:<\/jats:title>\n            <jats:p>10.17605\/OSF.IO\/P6YB9<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028186","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T13:06:57Z","timestamp":1639141617000},"page":"e28186","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The effectiveness of cyclosporine A for patients with steroid-resistant nephrotic syndrome"],"prefix":"10.1097","volume":"100","author":[{"given":"Juan","family":"Lv","sequence":"first","affiliation":[{"name":"College of Integrated Traditional Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine, Gansu, China"},{"name":"Department of Emergency, Gansu Hospital of Traditional Chinese Medicine, Gansu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizhi","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Song's Orthopedics, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Gansu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gansu Hospital of Traditional Chinese Medicine, Gansu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1927-1786","authenticated-orcid":false,"given":"Enlai","family":"Dai","sequence":"additional","affiliation":[{"name":"Integrated Traditional Chinese and Western Medicine College, Gansu University of Traditional Chinese Medicine, Gansu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pcl.2018.08.006","article-title":"Nephrotic syndrome","volume":"66","author":"Wang","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/20469047.2017.1374003","article-title":"Nephrotic syndrome in infants and children: pathophysiology and management","volume":"37","author":"Downie","year":"2017","journal-title":"Paediatr Int Child Health"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"121","DOI":"10.12688\/f1000research.10165.1","article-title":"Recent advances in understanding and treating nephrotic syndrome","volume":"6","author":"Bierzynska","year":"2017","journal-title":"F1000Res"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ncp.10622","article-title":"Pediatric nephrotic syndrome: pharmacologic and nutrition management","volume":"36","author":"Hampson","year":"2021","journal-title":"Nutr Clin Pract"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S2352-4642(18)30283-9","article-title":"Management of steroid-resistant nephrotic syndrome in children and adolescents","volume":"2","author":"Tullus","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1681\/ASN.2016101121","article-title":"Long-term outcome of steroid-resistant nephrotic syndrome in children","volume":"28","author":"Trautmann","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00467-016-3459-5","article-title":"Steroid-resistant nephrotic syndrome: a persistent challenge for pediatric nephrology","volume":"32","author":"Dogra","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5455\/msm.2018.30.84-88","article-title":"Children with steroid-resistant nephrotic syndrome: a single -center experience","volume":"30","author":"Pokrajac","year":"2018","journal-title":"Mater Sociomed"},{"key":"R10-20250504","article-title":"Interventions for idiopathic steroid-resistant nephrotic syndrome in children","volume":"2019","author":"Liu","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fped.2015.00104","article-title":"Long-term outcomes in children with steroid-resistant nephrotic syndrome treated with calcineurin inhibitors","volume":"3","author":"Beins","year":"2015","journal-title":"Front Pediatr"},{"key":"R12-20250504","first-page":"323","article-title":"Using mycophenolate mofetil in steroid-resistant nephrotic syndrome","volume":"6","author":"Ganji","year":"2012","journal-title":"Iran J Kidney Dis"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00467-005-2084-5","article-title":"Experience of renal biopsy in children with nephrotic syndrome","volume":"21","author":"Nammalwar","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R15-20250504","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.20105.1","article-title":"Podocyte RhoGTPases: new therapeutic targets for nephrotic syndrome?","volume":"8","author":"Saleem","year":"2019","journal-title":"F1000Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"6215946","DOI":"10.1155\/2018\/6215946","article-title":"Nephrotic syndrome: genetics, mechanism, and therapies","volume":"2018","author":"Shin","year":"2018","journal-title":"Biomed Res Int"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00467-016-3456-8","article-title":"Genetics of childhood steroid-sensitive nephrotic syndrome","volume":"32","author":"Karp","year":"2017","journal-title":"Pediatr Nephrol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:08:39Z","timestamp":1746335319000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028186"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":17,"journal-issue":{"issue":"49","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028186","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,12,10]]},"assertion":[{"value":"2021-11-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}